{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,4]],"date-time":"2026-02-04T16:39:43Z","timestamp":1770223183449,"version":"3.49.0"},"reference-count":60,"publisher":"Springer Science and Business Media LLC","issue":"1","content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Vet Res"],"published-print":{"date-parts":[[2017,12]]},"DOI":"10.1186\/s12917-017-1212-3","type":"journal-article","created":{"date-parts":[[2017,9,29]],"date-time":"2017-09-29T19:22:53Z","timestamp":1506712973000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["In vitro susceptibility of Borrelia burgdorferi isolates to three antibiotics commonly used for treating equine Lyme disease"],"prefix":"10.1186","volume":"13","author":[{"given":"Sanjie","family":"Caol","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thomas","family":"Divers","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7062-2804","authenticated-orcid":false,"given":"Mark","family":"Crisman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yung-Fu","family":"Chang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2017,9,29]]},"reference":[{"key":"1212_CR1","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1016\/S0140-6736(11)60103-7","volume":"379","author":"G Stanek","year":"2012","unstructured":"Stanek G, Wormser GP, Gray JS, Strle F. Lyme borreliosis. Lancet. 2012;379:461\u201373.","journal-title":"Lancet"},{"key":"1212_CR2","doi-asserted-by":"crossref","first-page":"7350","DOI":"10.1128\/AEM.01671-15","volume":"81","author":"NH Ogden","year":"2015","unstructured":"Ogden NH, Feil EJ, Leighton PA, Lindsay LR, Margos G, Mechai S, Michel P, Moriarty TJ. Evolutionary aspects of emerging Lyme disease in Canada. Appl Environ Microbiol. 2015;81:7350\u20139.","journal-title":"Appl Environ Microbiol"},{"key":"1212_CR3","doi-asserted-by":"crossref","first-page":"1562","DOI":"10.1128\/CVI.05123-11","volume":"18","author":"PD Burbelo","year":"2011","unstructured":"Burbelo PD, Bren KE, Ching KH, Coleman A, Yang X, Kariiu T, Iadarola MJ, Pal U. Antibody profiling of Borrelia burgdorferi infection in horses. Clin Vaccine Immunol. 2011;18:1562\u20137.","journal-title":"Clin Vaccine Immunol"},{"key":"1212_CR4","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.2460\/javma.2000.217.1045","volume":"217","author":"LA Magnarelli","year":"2000","unstructured":"Magnarelli LA, Ido JW, Van Andel AE, Wu C, Padula SJ, Fikrig E. Serologic confirmation of Ehrlichia equi and Borrelia burgdorferi infections in horses from the Northeastern United States. J Am Vet Med Assoc. 2000;217:1045\u201350.","journal-title":"J Am Vet Med Assoc"},{"issue":"4","key":"1212_CR5","doi-asserted-by":"crossref","first-page":"1300","DOI":"10.1111\/jvim.13973","volume":"30","author":"RA Funk","year":"2016","unstructured":"Funk RA, Pleasant RS, Witonsky SG, Reeder DS, Werre SR, Hodgson DR. Seroprevalence of Borrelia burgdorferi in horses presented for Coggins testing in Southwest Virginia and change in positive test results approximately one year later. J Vet Intern Med. 2016;30(4):1300\u20134.","journal-title":"J Vet Intern Med"},{"key":"1212_CR6","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1016\/j.jevs.2011.03.007","volume":"31","author":"AZ Durrani","year":"2011","unstructured":"Durrani AZ, Goyal SM, Kamal N. Retrospective study of seroprevalence of Borrelia burgdorferi antibodies in horses in Minnesota. J Equine Vet Sci. 2011;31:427\u20139.","journal-title":"J Equine Vet Sci."},{"key":"1212_CR7","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1016\/j.jevs.2008.08.010","volume":"28","author":"KB Metcalf","year":"2008","unstructured":"Metcalf KB, Lilley CS, Revenaugh MS, Glaser AL, Metcalf ES. The prevalence of antibodies against Borrelia burgdorferi found in horses residing in the Northwestern United States. J Equine Vet Sci. 2008;28:587\u20139.","journal-title":"J Equine Vet Sci"},{"key":"1212_CR8","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1111\/j.1463-5224.2012.01000.x","volume":"15","author":"HL Priest","year":"2012","unstructured":"Priest HL, Irby NL, Schlafer DH, Divers TJ, Wagner B, Glaser AL, Chang YF, Smith MC. Diagnosis of Borrelia-associated uveitis in two horses. Vet Ophthalmol. 2012;15:398\u2013405.","journal-title":"Vet Ophthalmol"},{"key":"1212_CR9","doi-asserted-by":"crossref","first-page":"1180","DOI":"10.2460\/javma.237.10.1180","volume":"237","author":"FM James","year":"2010","unstructured":"James FM, Engiles JB, Beech J. Meningitis, cranial neuritis, and radiculoneuritis associated with Borrelia burgdorferi infection in a horse. J Am Vet Med Assoc. 2010;237:1180\u20135.","journal-title":"J Am Vet Med Assoc"},{"key":"1212_CR10","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1177\/0300985811398246","volume":"48","author":"DM Imai","year":"2011","unstructured":"Imai DM, Barr BC, Daft B, Bertone JJ, Feng S, Hodzic E, Johnston JM, Olsen KJ, Barthold SW. Lyme neuroborreliosis in two horses. Vet Pathol. 2011;48:1151\u20137.","journal-title":"Vet Pathol"},{"key":"1212_CR11","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1111\/j.1365-3164.2011.01013.x","volume":"23","author":"KP Sears","year":"2012","unstructured":"Sears KP, Divers TJ, Neff RT, Miller WH Jr, McDonough SP. A case of Borrelia-associated cutaneous pseudolymphoma in a horse. Vet Dermatol. 2012;23:153\u20136.","journal-title":"Vet Dermatol"},{"key":"1212_CR12","doi-asserted-by":"crossref","unstructured":"Passamonti F, Veronesi F, Cappelli K, Capomaccio S, Reginato A, Miglio A, Vardi DM, Stefanetti V, Coletti M, Bazzica C, Pepe M. Polysynovitis in a horse due to Borrelia burgdorferi sensu lato infection - case study. Ann Agric Environ Med. 2015;22:247\u201350.","DOI":"10.5604\/12321966.1152074"},{"key":"1212_CR13","doi-asserted-by":"crossref","first-page":"1457","DOI":"10.2460\/javma.1987.191.11.1457","volume":"191","author":"EC Burgess","year":"1987","unstructured":"Burgess EC, Mattison M. Encephalitis associated with Borrelia burgdorferi infection in a horse. J Am Vet Med Assoc. 1987;191:1457\u20138.","journal-title":"J Am Vet Med Assoc"},{"key":"1212_CR14","doi-asserted-by":"crossref","first-page":"1340","DOI":"10.2460\/javma.1986.189.10.1340","volume":"189","author":"EC Burgess","year":"1986","unstructured":"Burgess EC, Gillette D, Pickett JP. Arthritis and panuveitis as manifestations of Borrelia burgdorferi infection in a Wisconsin pony. J Am Vet Med Assoc. 1986;189:1340\u20132.","journal-title":"J Am Vet Med Assoc"},{"key":"1212_CR15","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1111\/j.2042-3306.1996.tb01595.x","volume":"28","author":"CN Hahn","year":"1996","unstructured":"Hahn CN, Mayhew IG, Whitwell KE, Smith KC, Carey D, Carter SD. A possible case of Lyme borreliosis in a horse in the UK. Equine Vet J. 1996;28:84\u20138.","journal-title":"Equine Vet J"},{"key":"1212_CR16","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1016\/j.cll.2015.08.004","volume":"35","author":"JL Sanchez","year":"2015","unstructured":"Sanchez JL. Clinical manifestations and treatment of Lyme disease. Clin Lab Med. 2015;35:765\u20138.","journal-title":"Clin Lab Med"},{"key":"1212_CR17","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1586\/14787210.2014.940900","volume":"12","author":"DJ Cameron","year":"2014","unstructured":"Cameron DJ, Johnson LB, Maloney EL. Evidence assessments and guidelines recommendations in Lyme disease: the clinical management of known tick bites, erythema migrans rashes and persistent disease. Expert Rev Anti-Infect Ther. 2014;12:1103\u201335.","journal-title":"Expert Rev Anti-Infect Ther"},{"key":"1212_CR18","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1556\/AVet.2012.036","volume":"60","author":"TJ Divers","year":"2012","unstructured":"Divers TJ, Grice AL, Mohammed HO, Glaser AL, Wagner B. Changes in Borrelia burgdorferi ELISA antibody over time in both antibiotic treated and untreated horses. Acta Vet Hung. 2012;60:421\u20139.","journal-title":"Acta Vet Hung"},{"key":"1212_CR19","doi-asserted-by":"crossref","first-page":"2133","DOI":"10.1128\/AAC.34.11.2133","volume":"34","author":"RC Johnson","year":"1990","unstructured":"Johnson RC, Kodner CB, Jurkovich PJ, Collins JJ. Comparative in vitro and in vivo susceptibilities of the Lyme disease spirochete Borrelia burgdorferi to cefuroxime and other antimicrobial agents. Amtimicrob Agents Chemother. 1990;34:2133\u20136.","journal-title":"Amtimicrob Agents Chemother"},{"key":"1212_CR20","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.ttbdis.2009.11.004","volume":"1","author":"L Ates","year":"2010","unstructured":"Ates L, Hanssen-H\u00fcbner C, Norris DE, Richter D, Kraiczy P, Hunfeld KP. Comparison of in vitro activities of tigecycline, doxycycline, and tetracycline against the spirochete Borrelia burgdorferi. Ticks Tick Borne Dis. 2010;1:30\u20134.","journal-title":"Ticks Tick Borne Dis"},{"key":"1212_CR21","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1093\/jac\/25.suppl_A.33","volume":"25","author":"RC Johnson","year":"1990","unstructured":"Johnson RC, Kodner C, Russell M, Girard D. In-vitro and in-vivo susceptibility of Borrelia burgdorferi to azithromycin. J Antimicrob Chemother. 1990;25:33\u20138.","journal-title":"J Antimicrob Chemother"},{"key":"1212_CR22","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1007\/s00508-006-0693-z","volume":"22","author":"KP Hunfeld","year":"2006","unstructured":"Hunfeld KP, Brade V. Antimicrobial susceptibility of Borrelia burgdorferi sensu lato: what we know, what we don\u2019t know, and what we need to know. Wien Klin Wochenschr. 2006;22:659\u201368.","journal-title":"Wien Klin Wochenschr"},{"key":"1212_CR23","first-page":"549","volume":"57","author":"SE Johnson","year":"1984","unstructured":"Johnson SE, Klein GC, Schmid GP, Feeley JC. Susceptibility of the Lyme disease spirochete to seven antimicrobial agents. Yale J Biol Med. 1984;57:549\u201353.","journal-title":"Yale J Biol Med."},{"key":"1212_CR24","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/S0924-8579(00)00116-3","volume":"15","author":"KP Hunfeld","year":"2000","unstructured":"Hunfeld KP, Kraiczy P, Winchelhaus TA, Sch\u00e4fer V, Brade V. Colorimetric in vitro susceptibility testing of penicillins, cephalosporins, macrolides, streptogramins, tetracyclines, and aminoglycosides against Borrelia burgdorferi isolates. Int J Antimicrob Agents. 2000;15:11\u20137.","journal-title":"Int J Antimicrob Agents"},{"key":"1212_CR25","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1007\/BF01780660","volume":"24","author":"R Baradaran-Dilmaghani","year":"1996","unstructured":"Baradaran-Dilmaghani R, Stanek G. In vitro susceptibility of thirty Borrelia strains from various sources against eight antimicrobial chemotherapeutics. Infection. 1996;24:60\u20133.","journal-title":"Infection"},{"key":"1212_CR26","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1093\/jac\/dkn551","volume":"63","author":"X Yang","year":"2009","unstructured":"Yang X, Nguyven A, Qiu D, Luft BJ. In vitro activity of tigecycline against multiple strains of Borrelia burgdoferi. J Antimicrob Chemother. 2009;63:709\u201312.","journal-title":"J Antimicrob Chemother"},{"key":"1212_CR27","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1128\/AAC.31.2.164","volume":"31","author":"RC Johnson","year":"1987","unstructured":"Johnson RC, Kodner DC, Russell M. In vitro and in vivo susceptibility of the Lyme disease spirochete, Borrelia burgdoferi, to four antimicrobial agents. Antimicrob Agents Chemother. 1987;31:164\u20137.","journal-title":"Antimicrob Agents Chemother"},{"key":"1212_CR28","doi-asserted-by":"crossref","first-page":"2692","DOI":"10.1128\/JCM.30.10.2692-2697.1992","volume":"30","author":"LL Dever","year":"1992","unstructured":"Dever LL, Jorgensen JH, Barbour AG. In vitro antimicrobial susceptibility testing of Borrelia burgdorferi: a microdilution MIC method and time-kill studies. J Clin Microbiol. 1992;30:2692\u20137.","journal-title":"J Clin Microbiol"},{"key":"1212_CR29","doi-asserted-by":"crossref","first-page":"355","DOI":"10.4142\/jvs.2006.7.4.355","volume":"7","author":"D Kim","year":"2006","unstructured":"Kim D, Kordick D, Divers T, Chang YF. In vitro susceptibilities of Leptospira spp. and Borrelia burgdorferi isolates to amoxicillin, tilmicosin, and enrofloxacin. J Vet Sci. 2006;7:355\u20139.","journal-title":"J Vet Sci"},{"key":"1212_CR30","first-page":"97","volume":"4","author":"E Sapi","year":"2011","unstructured":"Sapi E, Kaur N, Ananwu S, Luecke DF, Luecke DF, Datar A, Patel S, Rossi M, Stricker RB. Evaluation of in-vitro antibiotic susceptibility of different morphological forms of Borrelia burgdoferi. Infect Drug Resist. 2011;4:97\u2013113.","journal-title":"Infect Drug Resist"},{"key":"1212_CR31","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1111\/j.1699-0463.1999.tb01594.x","volume":"107","author":"O Brorson","year":"1999","unstructured":"Brorson O, Brorson SH. An in vitro study of the susceptibility of mobile and cystic forms of Borrelia burgdorferi to metronidazole. APMIS. 1999;107:566\u201376.","journal-title":"APMIS"},{"key":"1212_CR32","doi-asserted-by":"crossref","first-page":"e49","DOI":"10.1038\/emi.2014.53","volume":"3","author":"J Feng","year":"2014","unstructured":"Feng J, Wang T, Shi W, Zhang S, Sullivan D, Auwaerter PG, Zhang Y. Identification of novel activity against Borrelia burgdorferi persisters using an FDA approved drug library. Emerg Microbes Infect. 2014;3:e49.","journal-title":"Emerg Microbes Infect"},{"key":"1212_CR33","doi-asserted-by":"crossref","first-page":"233","DOI":"10.2746\/042516400776563608","volume":"32","author":"JE Bryant","year":"2000","unstructured":"Bryant JE, Brown MP, Gronwall RR, Merritt KA. Study of intragastric administration of doxycycline: pharmacokinetics including body fluid, endometrial and minimum inhibitory concentrations. Equine Vet J. 2000;32:233\u20138.","journal-title":"Equine Vet J"},{"key":"1212_CR34","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1111\/j.2042-3306.2011.00459.x","volume":"44","author":"LV Schnabel","year":"2012","unstructured":"Schnabel LV, Papich MG, Divers TJ, Altier C, Aprea MS, McCarrel TM, Fortier LA. Pharmacokinetics and distribution of minocycline in mature horses after oral administration of multiple doses and comparison with minimum inhibitory concentrations. Equine Vet J. 2012;44:453\u20138.","journal-title":"Equine Vet J"},{"key":"1212_CR35","doi-asserted-by":"crossref","first-page":"310","DOI":"10.2460\/ajvr.67.2.310","volume":"67","author":"JL Davies","year":"2006","unstructured":"Davies JL, Salmon JH, Papich MG. Pharmacokinetics and tissue distribution of doxycycline after oral administration of single and multiple doses in horses. Am J Vet Res. 2006;67:310\u20136.","journal-title":"Am J Vet Res"},{"key":"1212_CR36","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1111\/j.1365-2885.2011.01351.x","volume":"35","author":"M Leclere","year":"2012","unstructured":"Leclere M, Magdesian KG, Cole CA, Szabo NJ, Ruby RE, Rhodes DM, Edman J, Vale A, Wilson WD, Tell LA. Pharmacokinetics and preliminary safety evaluation of azithromycin in adult horses. J Vet Pharmacol Ther. 2012;35:541\u20139.","journal-title":"J Vet Pharmacol Ther"},{"key":"1212_CR37","doi-asserted-by":"crossref","first-page":"1688","DOI":"10.2460\/ajvr.1988.49.10.1688","volume":"49","author":"WD Wilson","year":"1988","unstructured":"Wilson WD, Spensley MS, Baggot JD, Hietala SK. Pharmacokinetics and estimated bioavailability of amoxicillin in mares after intravenous, intramuscular, and oral administration. Am J Vet Res. 1988;49:1688\u201394.","journal-title":"Am J Vet Res"},{"key":"1212_CR38","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1111\/j.1365-2885.1992.tb01010.x","volume":"15","author":"JM Ensink","year":"1992","unstructured":"Ensink JM, Klein WR, Mevius DJ, Klarenbeek A, Vulto AG. Bioavailability of oral penicillins in the horse: a comparison of pivampicillin and amoxicillin. J Vet Pharmacol Ther. 1992;15:221\u201330.","journal-title":"J Vet Pharmacol Ther"},{"key":"1212_CR39","first-page":"262","volume-title":"Antimicrobial therapy in veterinary medicine","author":"JFE de Castillo","year":"2013","unstructured":"de Castillo JFE. Tetracyclines. In: Gigu\u00e8re S, Prescott JF, Dowling PM, editors. Antimicrobial therapy in veterinary medicine. 5th ed. Hoboken: John Wiley Blackwell; 2013. p. 262.","edition":"5"},{"key":"1212_CR40","first-page":"521","volume":"57","author":"AG Barbour","year":"1984","unstructured":"Barbour AG. Isolation and cultivation of Lyme disease spirochetes. Yale J Biol Med. 1984;57:521\u20135.","journal-title":"Yale J Biol Med"},{"key":"1212_CR41","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/S0934-8840(11)80890-X","volume":"283","author":"J Boerner","year":"1995","unstructured":"Boerner J, Failing K, Wittenbrink MM. In vitro antimicrobial susceptibility of Borrelia burgdorferi: influence of test conditions on minimal inhibitory concentration (MIC) values. Zenetralbl Bakteriol. 1995;283:49\u201360.","journal-title":"Zenetralbl Bakteriol"},{"key":"1212_CR42","doi-asserted-by":"crossref","first-page":"1791","DOI":"10.1128\/JCM.41.4.1791-1793.2003","volume":"41","author":"M Sicklinger","year":"2003","unstructured":"Sicklinger M, Wienecke R, Nubert U. In vitro susceptibility testing of four antibiotics against Borrelia burgdorferi: a comparison of results for the three genospecies Borrelia afzelii, Borrelia garinii, and Borrelia burgdoferi sensu stricto. J Clin Microbiol. 2003;41:1791\u20133.","journal-title":"J Clin Microbiol"},{"key":"1212_CR43","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1177\/104063879600800309","volume":"8","author":"SA Salmon","year":"1996","unstructured":"Salmon SA, Watts JL, Yancey RJ Jr. In vitro activity of ceftiofur and its primary metabolite, desfuroylceftiofur, against organisms of veterinary importance. J Vet Diagn Investig. 1996;8:332\u20136.","journal-title":"J Vet Diagn Investig"},{"key":"1212_CR44","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1111\/evj.12192","volume":"46","author":"D Scofield","year":"2014","unstructured":"Scofield D, Black J, Wittenburg L, Gustafson D, Ferris R, Hatzel J, Traub-Dargatz J, McCue P. Endometrial tissue and blood plasma concentration of ceftiofur and metabolites following intramuscular administration of ceftiofur crystalline free acid to mares. Equine Vet J. 2014;46:606\u201310.","journal-title":"Equine Vet J"},{"key":"1212_CR45","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1111\/j.1365-2885.2011.01266.x","volume":"34","author":"WT Collard","year":"2011","unstructured":"Collard WT, Cox SR, Lesman SP, Grover GS, Boucher JF, Hallberg JW, Robinson JA, Brown SA. Pharmacokinetics of ceftiofur crystalline-free acid sterile suspension in the equine. J Vet Pharmacol Ther. 2011;34:476\u201381.","journal-title":"J Vet Pharmacol Ther"},{"key":"1212_CR46","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1111\/evj.12107","volume":"46","author":"L Fultz","year":"2014","unstructured":"Fultz L, Gigu\u00e8re S, Berghaus LJ, Davis JL. Plasma and pulmonary pharmacokinetics of desfuroylceftiofur acetamide after weekly administration of ceftiofur crystalline free acid to adult horses. Equine Vet J. 2014;46:252\u20135.","journal-title":"Equine Vet J"},{"key":"1212_CR47","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1093\/jac\/dkf803","volume":"50","author":"R Auckenthaler","year":"2002","unstructured":"Auckenthaler R. Pharmacokinetics and pharmacodynamics of oral beta-lactam antibiotics as a two-dimensional approach to their efficacy. J Antimicrob Chemother. 2002;50:13\u20137.","journal-title":"J Antimicrob Chemother"},{"key":"1212_CR48","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/j.vetmic.2005.02.006","volume":"107","author":"YF Chang","year":"2005","unstructured":"Chang YF, Ku YW, Chang CF, Chang CD, McDonough SP, Divers T, Pough M, Torres A. Antibiotic treatment of experimentally Borrelia burgdoferi-infected ponies. Vet Microbiol. 2005;107:285\u201394.","journal-title":"Vet Microbiol"},{"key":"1212_CR49","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1016\/j.theriogenology.2010.02.030","volume":"74","author":"TS Witte","year":"2010","unstructured":"Witte TS, Bergwerff AA, Scherpenisse P, Drillich M, Heuwieser W. Ceftiofur derivates in serum and endometrial tissue after intramuscular administration in healthy mares. Theriogenol. 2010;74:466\u201372.","journal-title":"Theriogenol"},{"key":"1212_CR50","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1186\/s12917-015-0475-9","volume":"11","author":"B Wagner","year":"2015","unstructured":"Wagner B, Johnson J, Garcia-Tapia D, Honsberger N, King V, Strietzel C, Hardham JM, Heinz TJ, Marconi RT, Meeus PFM. Comparison of effectiveness of cefovecin, doxycycline, and amoxicillin for the treatment of experimentally induced early Lyme borreliosis in dogs. BMC Vet Res. 2015;11:163\u201370.","journal-title":"BMC Vet Res"},{"key":"1212_CR51","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/j.idc.2015.02.004","volume":"29","author":"SL Arvikar","year":"2015","unstructured":"Arvikar SL, Steere AC. Diagnosis and treatment of Lyme arthritis. Infect Dis Clin N Am. 2015;29:269\u201380.","journal-title":"Infect Dis Clin N Am"},{"key":"1212_CR52","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1093\/ofid\/ofv178","volume":"2","author":"NW Carris","year":"2015","unstructured":"Carris NW, Pardo J, Montero J, Shaeer KM. Minocycline as a substitute for doxycycline in targeted scenarios: a systematic review. Open Forum Infect Dis. 2015;2:178\u201389.","journal-title":"Open Forum Infect Dis"},{"key":"1212_CR53","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.1111\/ene.12744","volume":"22","author":"R Dersch","year":"2015","unstructured":"Dersch R, Freitag MH, Schmidt S, Sommer H, Rauer S, Meerpohl JJ. Efficacy and safety of pharmacological treatments for acute Lyme neuroborreliosis - a systemic review. Eur J Neurol. 2015;22:1249\u201359.","journal-title":"Eur J Neurol"},{"key":"1212_CR54","doi-asserted-by":"crossref","first-page":"355","DOI":"10.2165\/00003088-198815060-00001","volume":"15","author":"S Salvin","year":"1988","unstructured":"Salvin S, Houin G. Clinical pharmacokinetics of doxycycline and minocycline. Clin Pharmacokinet. 1988;15:355\u201366.","journal-title":"Clin Pharmacokinet"},{"key":"1212_CR55","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1111\/j.1463-5224.2005.00422.x","volume":"8","author":"MA Gilmour","year":"2005","unstructured":"Gilmour MA, Clarke CR, MacAllister CG, Dedeo JM, Dl C, Morton DJ. Pugh M. Ocular penetration of oral doxycycline in the horse. Vet Ophthalmol. 2005;8:331\u20135.","journal-title":"Vet Ophthalmol"},{"key":"1212_CR56","doi-asserted-by":"crossref","first-page":"208","DOI":"10.2746\/042516409X478514","volume":"42","author":"LV Schnabel","year":"2010","unstructured":"Schnabel LV, Papich MG, Watts AE, et al. Orally administered doxycycline accumulates in synovial fluid compared to plasma. Equine Vet J. 2010;42:208\u201312.","journal-title":"Equine Vet J"},{"key":"1212_CR57","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1002\/jor.21006","volume":"28","author":"LA Fortier","year":"2010","unstructured":"Fortier LA, Motta T, Greenwald RA, Divers TJ, Mayr KG. Synoviocytes are more sensitive than cartilage to the effect of minocycline and doxycycline on IL-1alpha and MMP-13-induced catabolic gene responses. J Orthop Res. 2010;28:522\u20138.","journal-title":"J Orthop Res"},{"key":"1212_CR58","doi-asserted-by":"crossref","first-page":"1379","DOI":"10.1086\/597807","volume":"199","author":"AL Bernardino","year":"2009","unstructured":"Bernardino AL, Kaukshal D, Philipp MT. The antibiotics doxycycline and minocycline inhibit the inflammatory responses to the Lyme disease spirochete Borrelia burgdorferi. J Infect Dis. 2009;199:1379\u201388.","journal-title":"J Infect Dis"},{"key":"1212_CR59","doi-asserted-by":"crossref","first-page":"119","DOI":"10.2460\/javma.1973.162.02.119","volume":"162","author":"RH Teske","year":"1973","unstructured":"Teske RH, Rollins LD, Condon RJ, Carter GG. Serum oxytetracycline concentrations after intravenous and intramuscular administration in horses. J Am Vet Med Assoc. 1973;162:119\u201320.","journal-title":"J Am Vet Med Assoc"},{"key":"1212_CR60","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1093\/cid\/cit810","volume":"58","author":"PM Lantos","year":"2014","unstructured":"Lantos PM, Auwaerter PG, Wormser GP. A systematic review of Borrelia burgdorferi morphologic variants does not support a role in chronic Lyme disease. Clin Infect Dis. 2014;58:663\u201371.","journal-title":"Clin Infect Dis"}],"container-title":["BMC Veterinary Research"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12917-017-1212-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,25]],"date-time":"2025-06-25T23:21:07Z","timestamp":1750893667000},"score":1,"resource":{"primary":{"URL":"http:\/\/bmcvetres.biomedcentral.com\/articles\/10.1186\/s12917-017-1212-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,9,29]]},"references-count":60,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2017,12]]}},"alternative-id":["1212"],"URL":"https:\/\/doi.org\/10.1186\/s12917-017-1212-3","relation":{},"ISSN":["1746-6148"],"issn-type":[{"value":"1746-6148","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,9,29]]},"article-number":"293"}}